Tigermed (03347.HK): Has repurchased A-shares with a total consideration of approximately RMB 824 million

NewTimeSpace News: On July 2, 2026, Tigermed (03347.HK) issued an announcement regarding the progress of its share repurchase program. As of June 30, the Company had repurchased an aggregate of 20,963,478 A-shares via its dedicated share repurchase securities account under centralized bidding trading, representing 2.4347% of the total share capital, with total consideration of roughly RMB 824 million.

As disclosed in the announcement, the Company previously approved a share repurchase plan, under which it intends to repurchase A-shares using internal or self-raised funds with a total budget ranging from no less than RMB 500 million to no more than RMB 1 billion, at a maximum repurchase price of RMB 60 per share. The repurchased shares will be used for equity incentive plans, employee stock ownership schemes or cancellation for capital reduction, to be implemented within 12 months from the date of shareholder approval at the general meeting.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.